Noradrenaline is implicated in the modulation of attention and arousal, but the neuroanatomical basis of this effect in humans is unknown. A previous functional neuroimaging study failed to find clear effects of clonidine (␣2 adrenoceptor agonist) on activity of brain regions implicated in attention. Therefore, we now investigate whether clonidine affects the functional integration of a neuroanatomical attentional network, by modulating connectivity between brain regions rather than activity within discrete regions. Following infusion of either clonidine or placebo, positron emission tomography measurements of brain activity were collected in 13 normal subjects while they were either resting or performing an attentional task. Effective connectivity analysis showed that during rest, clonidine decreased the functional strength of connections both from frontal cortex to thalamus and in pathways to and from visual cortex. Conversely, during the attentional task, functional integration generally increased, with changes being centered on parietal cortex (increased connectivity from locus coeruleus to parietal cortex and from parietal cortex to thalamus and frontal cortex). A drug-induced increase in the modulatory effects of frontal cortex on projections from locus coeruleus to parietal cortex was also observed. Collectively, these results highlight cognitively dissociable effects of clonidine on interactions among functionally integrated brain regions and implicate the noradrenergic system in mediating the functional integration of attentional brain systems. The contextsensitive nature of the changes are consistent with observations that noradrenergic drugs have differential effects on brain processes depending on subjects' underlying arousal levels. More generally, the results illustrate the dynamic plasticity of cognitive brain systems following neurochemical challenge. 1999 Academic Press
INTRODUCTION
Neuropsychological and neuroimaging studies implicate frontal, parietal, and thalamic brain regions in the control of attention and working memory (for reviews see LaBerge, 1995; Smith and Jonides, 1997; Coull, 1998) . Experimental manipulations of the noradrenergic system are also known to modulate these processes in rats (see for reviews Aston-Jones et al., 1991; Robbins and Everitt, 1995) , monkeys (Arnsten and Contant, 1992; Aston-Jones et al., 1994; Witte and Marrocco, 1997; Arnsten et al., 1996) , and humans (Clark et al., 1989; Smith et al., 1992; Coull et al., 1995a,b) , with the ␣2 adrenoceptor subtype being particularly implicated. This receptor occurs both pre-and postsynaptically and the cognitive effects of drugs such as clonidine, a mixed ␣1/␣2 adrenoceptor agonist, or guanfacine, a more selective ␣2A agonist, have been shown to be strictly dose-dependant. Specifically, low doses of clonidine, acting on presynaptic receptors, tend to impair working memory performance, while higher doses, acting on postsynaptic receptors, tend to improve performance (Arnsten et al., 1988) . Studies in monkeys suggest supersensitive postsynaptic receptors in prefrontal cortex as the neuroanatomical substrate for this effect (Arnsten and Goldman-Rakic, 1985; Arnsten et al., 1996) . Moreover, Arnsten (1998) has integrated evidence from rat and monkey studies (Arnsten and Goldman-Rakic, 1984; Sara and Hervé-Minivielle, 1995; Rajkowski et al., 1998; Jodo et al., 1998) to suggest that noradrenergic activity in prefrontal cortex can influence firing of noradrenergic cell bodies in the locus coeruleus in order to modulate attentional function under varying states of arousal. The neuroanatomical basis of this effect in humans, however, is still not known.
The interaction between arousal level and the effects of ␣2 receptor agents on attentional performance is well documented. Effects of ␣2 drugs on cognition are greater during conditions of lowered arousal (Arnsten and Contant, 1992; Coull et al., 1995a Coull et al., , 1997 Smith and Nutt, 1996) , suggesting that states of high arousal (e.g., elicited by white noise or novelty) can attenuate the drugs' effect on attentional performance. We have also shown that these context-dependant effects can be measured in terms of regional brain activity, as well as by behavioral performance. Specifically, we observed selective reduction of thalamic activity by clonidine during conditions of low, rather than high, arousal (Coull et al., 1997) . We predicted that this may be partially underpinned by a drug effect on ␣2 receptors in frontal cortex that ''attenuate[d] activity in a frontothalamic loop'' and so ''in turn affect [ed] thalamic function'' (Coull et al., 1997) . With the advent of more sophisticated techniques for estimating functional integration, we are now able to test this hypothesis explicitly by estimating changes in effective connectivity among cortical and thalamic brain regions, following placebo or clonidine infusion during a low arousal resting state. Our specific hypothesis was that compared to placebo, clonidine would significantly alter measures of effective connectivity between frontal cortex and thalamus during rest. Effective connectivity is a measure of the influence that one brain region exerts over another and provides an index of functional integration among discrete brain regions (Friston, 1994; Friston et al., 1993; McIntosh and Gonzalez-Lima, 1994; Bü chel and Friston, 1997; Horwitz et al., 1999) . Effective connectivity analysis has previously been used to model functional changes in interregional connectivity during visual processing (McIntosh et al., 1994) , working memory (McIntosh et al., 1996) , attention (Bü chel and Friston, 1997) , episodic memory (Nyberg et al., 1998) , and learning (Bü chel et al., 1999; Fletcher et al., 1999) . Using the same method of analysis, we can measure changes in the functional strength of a putative anatomical connection (Horwitz et al., 1999) under different pharmacological states. While previous psychopharmacological neuroimaging studies have examined the effect of drug treatment on region-specific activity, we now extend this approach by looking for drug-induced modulations of effective connectivity between brain regions.
Previous studies have also emphasised drug-induced changes in task-dependent regional activity, as indexed by drug-by-task interactions (Friston et al., 1992) . In this study, we looked for drug-induced changes in effective connectivity that showed similar context sensitivity. Therefore, changes in effective connectivity were also assessed during performance of a task requiring attention and working memory, performance of which has previously been demonstrated to be impaired by clonidine (Coull et al., 1995a) . A functional neuroimaging study of the effects of clonidine on performance of this task revealed only subtle effects of the drug on activity of right frontal and parietal cortices, areas we had predicted to be deactivated by clonidine based on previous neuroimaging studies of attention and working memory and the neuroanatomy of noradrenergic pathways. We now investigate whether the effect of clonidine during performance of a task requiring attention and working memory is to alter the functional strength of connections between brain regions, rather than levels of activity within a region. Therefore, our second hypothesis was that, compared to placebo, clonidine would significantly alter effective connectivity between frontal and parietal cortices during an attentional task, but not during rest. Such task-specificity would provide direct evidence implicating the noradrenergic system in mediating the functional integration of attentional brain systems. A third, and related, hypothesis was based on findings suggesting that frontal projections to brain-stem locus coeruleus areas (Sara and Hervé-Minivielle, 1995; Jodo et al., 1998) may play a role in modulating coeruleal efferent pathways to other cortical areas (Aston-Jones et al., 1997) . In the context of our attention/working memory task, we predicted that frontal cortex activity would influence effective connectivity between locus coeruleus and parietal cortex, the latter being a region heavily implicated in attention and working memory.
MATERIALS AND METHODS

Subjects
Thirteen healthy male volunteers (11 right-handed; mean age 26.8, range 18-40) took part. Subjects were physically fit, and none were taking medication. The local hospital ethics committee approved the study, and permission to administer radioactive substances was obtained from the Advisory Committee on Radioactive Substances UK. Written informed consent was obtained. Subjects were assigned, in a double-blind and random manner, to the drug (6 subjects) or placebo (7 subjects) group.
PET Scanning
For each subject, 12 scans of regional cerebral blood flow (rCBF) were obtained using a CTI Model 953B PET scanner (CTI, Inc., Knoxville, TN) with collimating septa retracted. Radioactivity (total effective dose equivalent per subject was 5.0 mSv) was administered as a H 2 15 O bolus, infused over 20 s, followed by a 20-s saline flush. Ten-minute interscan intervals were used throughout, except for the 30-min interval immediately following drug/placebo administration, between scans 6 and 7. Integrated radioactivity counts accumulated over a 90-s acquisition period, beginning with the rising phase of radioactivity counts in the head, were used as an index of rCBF. A transmission scan, collected prior to the emission scans, was used to correct for attenuation effects.
Experimental Conditions and Design
Subjects were scanned 12 times while alternately resting quietly with eyes closed or performing the rapid visual information processing (RVIP) task. During this task, which requires both attention and working memory, digits were presented sequentially and foveally, in pseudo-random order, at a rate of 100 digits per minute for 2.5 min. Subjects detected target sequences of three prespecified, consecutive digits (1-3-5; 2-4-6; 3-5-7; 4-6-8). Further details of this task can be found in Coull et al. (1996) . The first six scans were collected before administration of drug or placebo. A 1.5 µg/kg (iv) dose of clonidine (6 subjects) or saline placebo (7 subjects) was administered directly after completion of the sixth scan. We used only the final six scans (postinfusion) for each subject in our effective connectivity analysis. This ensures a direct comparison of drug and placebo without the confounding effect of temporal order of drug administration.
PET Data Analysis
Images of radioactivity counts were analyzed using statistical parametric mapping (SPM96; Wellcome Department of Cognitive Neurology, London, UK; http:// www.fil.ion.ucl.ac.uk/spm) implemented in MATLAB (Mathworks, Inc., Natick, MA). Each of the 12 images was realigned to the first in order to correct for head movement between scans, normalized into a standard stereotactic space (Talairach and Tournoux, 1988) to allow for intersubject averaging, and then smoothed using a Gaussian filter of 20 ϫ 20 ϫ 12 mm (FWHM in x, y, and z planes, respectively), to accommodate intersubject differences in anatomy and to increase signal-tonoise ratio (Friston et al., 1995) . Indices of global activity were modeled as a confounding covariate (normalized to 50 ml/100 ml/min) using ANCOVA (Friston et al., 1990) . Linear contrasts were used to test for regionally specific condition effects, producing a t statistic for each voxel in brain space. These t statistics were transformed to corresponding Z values, and the resulting map of Z values constituted the statistical parametric map (SPM5Z6). These maps were thresholded at Z ϭ 4.10 (P ϭ 0.05 corrected for multiple comparisons). SPM5Z6s were used to define regions of interest for inclusion in our effective connectivity analysis.
Anatomical Model
We selected anatomical regions (8-mm radius) that (i) were significantly more active during RVIP scans than rest scans (Table 1a ) and (ii) showed an interaction between cognitive state (RVIP versus rest) and drug treatment (clonidine versus placebo) (Table 1b) . Specifically, these comprised posterior ventral extrastriate visual cortex (VC), intraparietal sulcus (IPS), posterior parietal cortex (PPC), thalamus, and inferior frontal gyrus (or ventral premotor cortex (BA44) (PMC) (Fig. 1 ). Based on previous neuroimaging and neuropsychological studies of attention, we concentrated solely on regions within the right hemisphere (Whitehead, 1991; Pardo et al., 1991; Paus et al., 1997; Coull et al., 1998; Sturm et al., 1999) . Coordinates of the maxima of each activation are given in Table 1a .
We also included a region centered on the locus coeruleus in the pontine region of the brain stem (Duvernoy, 1995) . This structure provides the main source of noradrenergic innervation of the cortex, thalamus, and limbic system. Although not previously reported (in Coull et al., 1997) , an assessment of the interaction between drug treatment and cognitive state revealed bilateral drug-induced deactivation of the locus coeruleus (LC) during rest but not during the RVIP condition (x, y, z ϭ Ϫ4, Ϫ32, Ϫ12; Z ϭ 3.26; P Ͻ 0.005, uncorrected for multiple comparisons; and x, y, z ϭ 4, Ϫ36, Ϫ12; Z ϭ 2.64; P Ͻ 0.005, uncorrected for multiple comparisons, in left and right hemispheres, respectively). This is a pattern of activity similar to that in the thalamus (Coull et al., 1997) . These two anatomically distinct peaks (24 mm separation between the two peaks) of deactivation are shown in Fig. 2 . Our anatomical model was right-lateralized, and therefore we included only the right-sided brainstem region in our model (Table 1b) .
We constructed an anatomical model, comprising putative connections between the above regions ( Fig.  1) , based on the existing neuroanatomical literature in nonhuman primates. For the purposes of comparative anatomy we assumed an analogy between human IPS and monkey LIP, human PPC with monkey area 7a, and human PMC with monkey ventral premotor cortex. Note. Stereotaxic coordinates refer to the atlas of Talairach and Tournoux (1988) and represent the center of an activated region of 8-mm radius. The Z score is a measure of significant change, the threshold for significance being set at Z Ͼ 3.09 (P Ͻ 0.001, uncorrected for multiple comparisons). We modeled connections from locus coeruleus to visual, parietal, and frontal cortices (Freedman et al., 1975; Gatter and Powell, 1977) ; visual cortex to parietal cortex (both IPS and PPC) and thalamus (Ungerleider and Mishkin, 1982; Ungerleider et al., 1983) ; PPC to IPS (Pandya and Seltzer, 1982) ; IPS to PMC (Cavada and Goldman-Rakic, 1989; Petrides and Pandya, 1984; Pandya and Yeterian, 1996) ; IPS to thalamus (Asanuma et al., 1985) ; and PMC to thalamus (Siweck and Pandya, 1991) . The connections were unidirectional to ensure mathematically robust estimates of connection strengths, and directionality was based on hierarchical cortical organization (Felleman and Van Essen, 1991) and our existing hypotheses regarding corticothalamic projections (Coull et al., 1997) .
Effective Connectivity Analysis
Using structural equation modeling and data adjusted for global flow and subject effects, we derived path coefficients (or ''connection strengths'') for the anatomical connections in our model and compared task-specific changes in effective connectivity in the placebo group to those in the clonidine group (see Bü chel and Friston (1997) for a full account of this method and McIntosh and Gonzalez-Lima (1994) or Horwitz et al. (1999) for an overview). Structural equation modeling (or path analysis) identifies connection strengths that best predict the observed variancecovariance structure of the empirical data, given the constraints of a prespecified anatomical model (Fig. 1) . A critical aspect, when interpreting the ensuing estimates, is a clear specification of the source of this covariance. Because we removed subject-specific effects and regionally nonspecific global effects from our data, before computing the covariances, the source of variance, and covariance, was entirely within subject. This is important because it means our estimates of the functional coupling between brain regions are based upon correlations among regional activities over time, as opposed to differences among subjects.
The path coefficients derived from the analysis represent the change in activity (in standard deviations) of a target area, for a unit change in activity (in standard deviations) of a source area. In other words, this reflects how strongly activity in the source area influences activity in the target area. A path coefficient with a value close to ϩ1 indicates that increases in the activity of one area are paralleled by increases in activity of the other, while a value closer to Ϫ1 indicates that increases in one area are paralleled by decreases in the other. The closer a value is to 0, the weaker is the effective connectivity (or functional integration) between the two regions in question. Although path coefficients can increase or decrease between groups, it is important to note that the natures of these quantitative changes can be qualitatively distinct. For example, an increase in path coefficient can imply that an already existing connection can be functionally strengthened by the drug (e.g., ϩ0.40 to ϩ0.80), that two areas that were once functionally uncoupled are now integrated (e.g., ϩ0.01 to ϩ0.60), or that two areas that were strongly connected but had opposing effects on each other are no longer functionally integrated (e.g., Ϫ0.60 to ϩ0.01). It is also important to note that we cannot make inferences about the mechanism of action of drug-induced change in effective connectivity, either inhibitory or excitatory, at a synaptic level (McIntosh and Gonzalez-Lima, 1994) . All inferences must be made at a systems level.
Statistical inferences about group differences were based on the comparison of a free model, in which all connections were allowed to vary between the two treatment groups, to a restricted model, in which a given connection was forced to be equal for both groups. The significance of the difference between models is expressed as the difference in 2 goodness of fit. The null hypothesis states that allowing connection strength to vary between placebo and drug groups will not significantly improve the fit of the model to the observed data. Two separate analyses were conducted: one using RVIP scans and one using rest scans.
An additional analysis was conducted in which rest and RVIP scans were analyzed together. Here, we were interested in the modulatory influence of frontal activity on the connection from LC to IPS, given both the physiological evidence that frontal cortex projects to, and influences activity of, locus coeruleus (Arnsten and Goldman-Rakic, 1984; Sara and Hervé-Minvielle, 1996; Jodo et al., 1998) and the neuropsychological evidence implicating activation of a frontoparietal network during attention (Corbetta et al., 1993; Pardo et al., 1991; Coull et al., 1998) . The method of analysis was identical to that described above except that an extra variable, the interaction (i.e., product) of activity in PMC and LC, was included in the model. This ''interaction'' or ''moderator'' variable was connected to IPS and represented the modulatory influence of PMC on the connection from LC to IPS (see Bü chel and Friston, 1997) .
Analysis of Behavioral Data
Measures of accuracy (mean percentage of correctly identified targets) were calculated separately for preand postinfusion scans for both placebo and clonidine subjects. A change score that represented postinfusion accuracy minus preinfusion accuracy was then computed for each subject. The change scores for placebo and clonidine groups were compared in a one-tailed, independent samples t test. In addition, we correlated the clonidine-induced change in accuracy of performance (mean corrected) to the clonidine-induced change in activity (mean corrected) in each of the key brain regions. Measures of performance accuracy were derived from the second minute of the task, during which the PET scanning data were collected, to facilitate direct correlations between brain activity and performance.
RESULTS
Behavioral Data
There was a nonsignificant trend (t(11) ϭ 1.2, P ϭ 0.13) for clonidine to impair performance on the RVIP task, compared to placebo (an improvement of 3.6% (Ϯ4.4) correct following placebo infusion compared to a decrement of 3.5% (Ϯ3.9) correct following clonidine infusion). In addition, there was a significant negative correlation between change in performance and change in IPS activity following clonidine infusion (r(6) ϭ Ϫ0.81, P Ͻ 0.03), such that the more performance was impaired by clonidine, the greater was the increase in IPS activity (Fig. 3) . Correlations between change in performance and change in activity of the five other regions were also performed, but these were not significant.
Direct Connections
During resting scans, the path coefficient (i.e., index of effective connectivity) from frontal cortex to thalamus was significantly reduced following administration of clonidine, compared to placebo ( 2 (1) ϭ 5.59, P Ͻ 0.02). We also looked for significant changes in connectivity among other regions following clonidine infusion and found significant decreases from LC to VC ( 2 (1) ϭ 3.84, P Ͻ 0.05), from VC to IPS ( 2 (1) ϭ 6.04, P Ͻ 0.01), and from VC to thalamus ( 2 (1) ϭ 9.61, P Ͻ 0.001) (Fig. 4a ). There were no other significant changes. Path coefficients (or functional connection strengths) for each of these connections are shown in Table 2a .
During scans in which subjects were performing the RVIP task clonidine-induced increases in path coefficients were observed from IPS to thalamus ( 2 (1) ϭ 9.71, P Ͻ 0.001) and from IPS to PMC ( 2 (1) ϭ 4.58, P Ͻ 0.03) (Fig. 4b) . Although clonidine treatment also increased the functional connection strength from LC to IPS ( 2 (1) ϭ 4.21, P Ͻ 0.04) (Table 2b), this increase was qualitatively different from those observed within forebrain areas. Specifically, clonidine administration attenuated the strong negative connection strength between LC and IPS, which was apparent in the placebo group, thus rendering the index of connectivity between these two regions close to zero. A decrease in effective connectivity was observed in the connection from PMC to thalamus ( 2 (1) ϭ 5.11, P Ͻ 0.02). Path coefficients for each of these connections are given in Table 2b .
The drug-induced decrease in effective connectivity from frontal cortex to thalamus was common to both conditions (rest and RVIP). All the other significant connections were selectively modulated during one or other condition, suggesting that adrenoceptor-mediated changes in effective connectivity are functionally specific or that task-specific changes in effective connectivity depend upon adrenoceptor binding.
Modulatory Effects of Frontal Cortex on Coeruleocortical Connections
Given the influence of frontal cortex on locus coeruleus activity in rats (Arnsten and Goldman-Rakic, 1984; Sara and Hervé-Minvielle, 1995; Jodo et al., 1998) , we also examined the modulatory influence of frontal activity on the connection from LC to IPS (Fig.  5) . A modulatory, rather than a direct, effect of frontal cortex on LC was investigated since it is thought that frontal cortex projects to a peri-LC zone containing numerous LC dendrites, rather than to the LC proper (Aston-Jones et al., 1986; Shipley et al., 1996; Zhu and Aston-Jones, 1996) . We focused on the modulation of the connection from LC to IPS given the strong neuroanatomical and neuropsychological evidence implicating a frontoparietal network in studies of attention and working memory (Corbetta et al., 1993; Pardo et al., 1991; Goldman-Rakic, 1988; Nobre et al., 1997; Smith and Jonides, 1997; Coull et al., 1998) .
Following infusion of clonidine, the modulatory influence of PMC on the connection from LC to IPS increased significantly compared to placebo ( 2 (1) ϭ 3.81, P ϭ 0.05; path coefficients of 0.07 and 0.32 in placebo and clonidine groups, respectively) (Fig. 5) .
DISCUSSION
This is the first examination of drug-induced changes in measures of effective connectivity (or functional integration) between distant brain regions in humans. We have identified neuroanatomically dissociable changes in effective connectivity following infusion of the ␣2 adrenoceptor agonist clonidine in two distinct cognitive states. In one condition, subjects were resting quietly with eyes closed, while in the other, subjects were engaged in a visual attention task (RVIP) that also taxed working memory. During resting conditions, clonidine treatment reduced functional integration between frontal cortex and thalamus and between posterior visual cortex and its targets. Conversely, during performance of the RVIP task, clonidine administration significantly affected functional integration between frontal and parietal cortices and between parietal FIG. 3. Significant negative correlation between the magnitude of clonidine-induced changes in performance (percentage of targets correctly detected during the period of the scan) and the right intraparietal sulcus (IPS) activity. Greater drug-induced decrements in performance are associated with greater increases in IPS activity. Clonidine-induced change is measured by subtracting the mean of the postinfusion scans from the mean of the preinfusion scans in the clonidine group (six subjects). cortex and thalamus. In addition, we found taskspecific effects of clonidine on connections from the noradrenergic cells of origin in the LC to neocortical areas. Compared to placebo, clonidine treatment decreased the influence of LC on visual cortex during resting conditions, but increased the influence of LC on intraparietal sulcus during performance of the RVIP task. Collectively, these results demonstrate neuroanatomically distinct context-sensitive changes in brain connectivity, from both a psychological and a pharmacological standpoint. More specifically, we have shown that the noradrenergic modulation of cognition or arousal is not underpinned by changes of activity within a single area, but rather depends on a cooperative network of brain regions.
Task-Specific Changes in Corticothalamic Networks
We had already hypothesized (Coull et al., 1997 ) that drug-induced decreases in thalamic activity during rest may be partially mediated by an effect of clonidine on a frontothalamic system, such that clonidine may influence frontal cortex activity, which in turn then affects thalamic activity. The results of the present analysis support this hypothesis and suggest additionally that clonidine-induced changes in functional integration between visual cortex and thalamus may also contribute to the thalamic deactivations. However, it is important to note that this explanation does not exclude the possibility that clonidine may also have been acting   FIG. 4 . Changes in measures of effective connectivity following clonidine infusion, relative to placebo, during (a) resting scans and (b) RVIP scans. Thin arrows, no difference between placebo and clonidine; thick black arrows, increased effective connectivity following clonidine infusion (P Ͻ 0.05); thick gray arrows, decreased effective connectivity following clonidine infusion (P Ͻ 0.05). directly on ␣2 receptors in the thalamus itself. The usefulness of the current analysis is to demonstrate that regionally specific drug effects (e.g., deactivation of thalamus by clonidine) may be partially contributed to by drug effects on a distant, yet influential, region.
Analysis of clonidine-induced changes in effective connectivity during the RVIP condition revealed increases in the functional strength of the connections from parietal cortex to both frontal cortex and thalamus, which was not observed during rest. These cortical areas have been strongly implicated in attention and working memory (Pardo et al., 1991; Corbetta et al., 1993; Coull et al., 1998; Jonides, 1997), and Goldman-Rakic (1988) has suggested that a frontoparietal network may be a better candidate for the neuroanatomical substrate of working memory than frontal cortex alone. Our results suggest that, with administration of clonidine, the functional integration between these two areas significantly increases. This is in contrast to the (nonsignificant) clonidine-induced decreases in activity within either region during performance of the task (see Coull et al., 1997) . This dissociation therefore confirms our hypothesis that in order to modulate cognitive performance, clonidine may preferentially modulate the functional integration of regions in an attentional network (particularly frontal and parietal cortices), rather than directly modulating activity within a discrete brain region.
Task-Specific Changes in Coeruleocortical Networks
Task-specific changes in connectivity between LC and its neocortical projection fields were also observed. Connectivity between LC and visual cortex during rest was reduced following clonidine administration. The LC in rats shows low levels of activity during behaviors characterized by low vigilance, such as sleeping or grooming (Foote et al., 1980; Aston-Jones and Bloom, 1981) , which can be compared to the resting condition in our study. Our data suggest that during this state of low arousal, LC firing is attenuated even further by clonidine administration (Svensson et al., 1975; Cedarbaum and Aghajanian, 1976) , and concomitantly the influence of LC on visual cortex is reduced.
During the RVIP condition, on the other hand, increased effective connectivity was observed between LC and IPS following clonidine treatment. The LC is activated by increases in arousal state, such as performance of cognitive tasks (Foote et al., 1980; AstonJones et al., 1991 AstonJones et al., , 1994 , and more specifically by meaningful target stimuli (Aston-Jones et al., 1994 . Changes in LC activity mirror changes in task performance and, over many trials, have actually been shown to precede changes in behavior (Aston-Jones et al., 1997) . This suggests that LC firing preempts subsequent performance, and reduction in LC activity following clonidine infusion (Svensson et al., 1975) could jeopardize subsequent cognitive performance (see also Ivanova et al., 1997) . We suggest that in an attempt to resume or maintain normal levels of RVIP performance following clonidine infusion, 2 the LC exerts a stronger influence on IPS activity (a region heavily implicated in the control of attention and working memory) than is required under normal (placebo) conditions. The significant correlation between clonidine-induced changes in performance and IPS activity supports this ''compensatory'' mechanism: the more performance deteriorates with clonidine, the more IPS activity must increase. The above interpretation would suggest that this relationship is mediated via the LC. Although the inverse relationship between performance and IPS activity may appear counterintuitive, it must be remembered that this represents a relative, rather than absolute, change in the level of regional activity. As already noted, we have evidence that activity in parietal cortex (as well as frontal and thalamic areas) actually tends to decrease in absolute terms following infusion of clonidine (Coull et al., 1997) . These increases in effective connectivity, in the face of decreases in regional activity, are suggestive of a retaliatory response of the brain to neurochemical challenge, rather than a direct effect of the drug on the connections themselves. This hypothesis illustrates the effect of clonidine on a network of areas which interact dynamically with one another in order to optimize behavior.
We have demonstrated, therefore, that the effects of clonidine administration on LC connectivity are taskspecific (decreased influence of LC on visual cortex during rest, but an increased influence of LC on IPS during the RVIP task). But by what mechanism does LC connectivity change according to the behavioral or cognitive context? Aston-Jones et al. (1997) have suggested that ''neuronal plasticity associated with . . . task [performance] occurs upstream of the LC, among its afferent circuits that are involved in decision making.'' The frontal cortex is an ideal candidate for modulating the efferent pathways of the LC, given the previously documented influence of prefrontal cortex on LC activity in rats (Sara and Hervé-Minvielle, 1995; Jodo et al., 1998) . We have explicitly modeled and observed drug-dependent increases in the modulatory effect of PMC on the functional strength of the connection from LC to parietal cortex after infusion of clonidine, suggesting that frontal cortex influences the degree of connectivity between LC and parietal cortex 2 Since clonidine's impairment of performance was statistically nonsignificant, subjects were effectively performing at ''normal'' levels. This supports our interpretation. Furthermore, this result suggests that changes in effective connectivity in the clonidine group are likely to reflect real neuromodulatory effects of the drug and not simply the inability of the subjects to perform the task (see Price and Friston (1999) for a similar argument applied to functional imaging studies of brain-damaged patients).
in a fashion that depends on the prevailing cognitive context.
Task-Specific Changes in Connectivity May Explain Arousal-Dependent Effects of Clonidine
Our results may explain why the cognitive and neurophysiological effects of clonidine are more apparent during states of relatively low arousal (Arnsten and Contant, 1992; Smith and Nutt, 1996; Coull et al., 1997; Coull, 1998) . During rest, the noradrenergic system is in a state of relative inactivity, as exemplified by a reduction in LC activity (e.g., Aston-Jones, 1991). Infusion of clonidine consolidates this quiescence (selective drug-induced reduction of LC activity during rest) and leads to functional uncoupling (decreases in effective connectivity) of selected brain regions. During periods of higher arousal, however, clonidine treatment increases the functional integration of regions implicated in attention and working memory (viz. frontal, parietal, and thalamic brain areas). This ''compensatory'' mechanism may mask the deleterious effects of the drug on, e.g., performance (Smith and Nutt, 1996) or regional brain activity (Coull et al., 1997) . Therefore, as well as revealing the neuroanatomical substrates of clonidine's effects on cognition, effective connectivity analysis of imaging data may help answer psychopharmacological questions about context-specific drug effects.
CONCLUSIONS
In conclusion, we have found task-specific, neuroanatomically dissociable effects of clonidine on the functional strength of connections among distributed brain regions during performance of a cognitive task compared to a low-arousal rest state. These results demonstrate that the noradrenergic modulation of cognition is unlikely to depend on modulation of activity within a single brain structure, but rather on cooperation of a distributed network of brain regions, acting together in a functionally integrated way. More generally, our data provide a clear example of the plasticity of brain function resulting from neurochemical challenge.
